In preclinical studies, some researchers have investigated the usefulness of some drugs, e.g., stimulator of interferon genes antagonist [75], huaiqihuan extractum [76], and human serum albumin-thioredoxin fusion protein [48], against cisplatin-induced AKI. The gene discussed is ALB; the disease is acute kidney injury.